PRESS
ContiVir in the media
2021
· Max Planck Institute Magdeburg
"Innovation Prize 2021 of the German BioRegions awarded to ContiVir"
ContiVir is awarded with the 2021 Innovation Prize of the German Bioregions with the topic "Purification tool to tackle vaccine bottlenecks".
· BIO Deutschland
"Innovationspreis der BioRegionen: angewandte Forschung in der Impf- und Wirkstoffforschung sowie Biomedizintechnik ausgezeichnet (German only)"
ContiVir is awarded with the 2021 Innovation Prize of the German Bioregions with the topic "Purification tool to tackle vaccine bottlenecks".
· National Geographic
"The world needs more vaccines, faster. A tiny tube could make all the difference"
Felipe Tapia discusses how ContiVir's Continuos Tubular Bioreactor (CTB) can revolutionize vaccine manufacturing.
· Max Planck Institute Magdeburg
"ContiVir offers purification tool to tackle viral gene therapy manufacturing bottlenecks"
Pavel Marichal and Julian Lopez discuss SXC's advantages as a purification tool for manufacturing of adeno adeno-associated virus (AAV), widely used in human gene therapy.
2020
· BBC News
"Coronavirus: cómo son las 6 vacunas contra el virus que ya se están probando en humanos y qué países están ganando la carrera" (Spanish only)
Felipe Tapia discusses the challenges on the global manufacturing of a coronavirus vaccine.
· Investieren in Sachsen-Anhalt
"ContiVir: Zwei neue Technologien für die Herstellung und Aufreinigung von viralen Vektoren werden kombiniert" (German only)
Pavel Marichal and Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.
· Max Planck Institute Magdeburg
"Scientists of the Bioprocess Engineering group receive a €1.1 Million Startup Grant to Advance Gene Therapy Manufacturing"
Pavel Marichal and Felipe Tapia are granted €1.1 Million to focus on the development of a continuous manufacturing platform for commercially relevant viral gene therapy vectors and vaccines.
· Nature.com
"If a coronavirus vaccine arrives, can the world make enough?"
Felipe Tapia comments on the production of a viral coronavirus vaccine.
· Cell & Gene Therapy Insights
"Suspension systems in continuous viral vector production processes"
Felipe Tapia discusses the different options for continuous culture of suspension cells for the production of virus particles.
2019
· Genetic Engineering & Biotechnology news
"Biopharma Keeps Shifting the Steel–Plastic Balance"
Pavel Marichal discusses the advantages of single-use systems over traditional steel technologies.
RELATED NEWS
2020
Nasdaq: "FDA Expects Explosion in Gene Therapy Treatments, Updates Review Policy"
Biopharma Reporter: "Yposkesi doubles manufacturing footprint to meet AAVs growing demand"
BBC News: "Gene Therapy to halt rare for of sight loss"
2019
The Guardian: "$2.1m Novartis gene therapy to become world's most expensive drug"
2017
The New York Times: "Gene Therapy Hits a Peculiar Roadblock: A Virus Shortage"
U.S Food and Drug Administration: "Modernizing the Way Drugs Are Made: A Transition to Continuous Manufacturing"
2016
American Pharmaceutical Review: "Achieving Large-Scale Cell and Gene Therapy Manufacturing"